COVID-19 Impact on Global Pharmaceutical Products and CMO Market Size, Status and Forecast 2020-2026

July 2020 | 127 pages | ID: C13C07D296F8EN
QYResearch

Abstracts

This report focuses on the global Pharmaceutical Products and CMO status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pharmaceutical Products and CMO development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Catalent
• DPx
• Lonza
• Piramal Healthcare
• Aenova
• Jubilant
• Famar
• Boehringer Ingelheim
• Fareva Holding
• AbbVie
• Nipro Corp
• Vetter
• Sopharma
• Mylan (DPT Laboratories)
• Recipharm
• NextPharma Technologies
• Dishman
• Aesica

Market segment by Type, the product can be split into

• Active Pharmaceutical Ingredient (API)
• Finished Dosage Form (FDF)
• Pharmaceutical Packaging

Market segment by Application, split into

• Specialty/Midsize
• Generics
• Big Pharma
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Pharmaceutical Products and CMO status, future forecast, growth opportunity, key market and key players.
• To present the Pharmaceutical Products and CMO development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Pharmaceutical Products and CMO are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Pharmaceutical Products and CMO Revenue
1.4 Market Analysis by Type
  1.4.1 Global Pharmaceutical Products and CMO Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Active Pharmaceutical Ingredient (API)
  1.4.3 Finished Dosage Form (FDF)
  1.4.4 Pharmaceutical Packaging
1.5 Market by Application
  1.5.1 Global Pharmaceutical Products and CMO Market Share by Application: 2020 VS 2026
  1.5.2 Specialty/Midsize
  1.5.3 Generics
  1.5.4 Big Pharma
  1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Pharmaceutical Products and CMO Industry Impact
  1.6.1 How the Covid-19 is Affecting the Pharmaceutical Products and CMO Industry
    1.6.1.1 Pharmaceutical Products and CMO Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Pharmaceutical Products and CMO Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Pharmaceutical Products and CMO Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Pharmaceutical Products and CMO Market Perspective (2015-2026)
2.2 Pharmaceutical Products and CMO Growth Trends by Regions
  2.2.1 Pharmaceutical Products and CMO Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Pharmaceutical Products and CMO Historic Market Share by Regions (2015-2020)
  2.2.3 Pharmaceutical Products and CMO Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Pharmaceutical Products and CMO Market Growth Strategy
  2.3.6 Primary Interviews with Key Pharmaceutical Products and CMO Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Pharmaceutical Products and CMO Players by Market Size
  3.1.1 Global Top Pharmaceutical Products and CMO Players by Revenue (2015-2020)
  3.1.2 Global Pharmaceutical Products and CMO Revenue Market Share by Players (2015-2020)
  3.1.3 Global Pharmaceutical Products and CMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Pharmaceutical Products and CMO Market Concentration Ratio
  3.2.1 Global Pharmaceutical Products and CMO Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Pharmaceutical Products and CMO Revenue in 2019
3.3 Pharmaceutical Products and CMO Key Players Head office and Area Served
3.4 Key Players Pharmaceutical Products and CMO Product Solution and Service
3.5 Date of Enter into Pharmaceutical Products and CMO Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Pharmaceutical Products and CMO Historic Market Size by Type (2015-2020)
4.2 Global Pharmaceutical Products and CMO Forecasted Market Size by Type (2021-2026)

5 PHARMACEUTICAL PRODUCTS AND CMO BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Pharmaceutical Products and CMO Market Size by Application (2015-2020)
5.2 Global Pharmaceutical Products and CMO Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Pharmaceutical Products and CMO Market Size (2015-2020)
6.2 Pharmaceutical Products and CMO Key Players in North America (2019-2020)
6.3 North America Pharmaceutical Products and CMO Market Size by Type (2015-2020)
6.4 North America Pharmaceutical Products and CMO Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Pharmaceutical Products and CMO Market Size (2015-2020)
7.2 Pharmaceutical Products and CMO Key Players in Europe (2019-2020)
7.3 Europe Pharmaceutical Products and CMO Market Size by Type (2015-2020)
7.4 Europe Pharmaceutical Products and CMO Market Size by Application (2015-2020)

8 CHINA

8.1 China Pharmaceutical Products and CMO Market Size (2015-2020)
8.2 Pharmaceutical Products and CMO Key Players in China (2019-2020)
8.3 China Pharmaceutical Products and CMO Market Size by Type (2015-2020)
8.4 China Pharmaceutical Products and CMO Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Pharmaceutical Products and CMO Market Size (2015-2020)
9.2 Pharmaceutical Products and CMO Key Players in Japan (2019-2020)
9.3 Japan Pharmaceutical Products and CMO Market Size by Type (2015-2020)
9.4 Japan Pharmaceutical Products and CMO Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Pharmaceutical Products and CMO Market Size (2015-2020)
10.2 Pharmaceutical Products and CMO Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Pharmaceutical Products and CMO Market Size by Type (2015-2020)
10.4 Southeast Asia Pharmaceutical Products and CMO Market Size by Application (2015-2020)

11 INDIA

11.1 India Pharmaceutical Products and CMO Market Size (2015-2020)
11.2 Pharmaceutical Products and CMO Key Players in India (2019-2020)
11.3 India Pharmaceutical Products and CMO Market Size by Type (2015-2020)
11.4 India Pharmaceutical Products and CMO Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Pharmaceutical Products and CMO Market Size (2015-2020)
12.2 Pharmaceutical Products and CMO Key Players in Central & South America (2019-2020)
12.3 Central & South America Pharmaceutical Products and CMO Market Size by Type (2015-2020)
12.4 Central & South America Pharmaceutical Products and CMO Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Catalent
  13.1.1 Catalent Company Details
  13.1.2 Catalent Business Overview and Its Total Revenue
  13.1.3 Catalent Pharmaceutical Products and CMO Introduction
  13.1.4 Catalent Revenue in Pharmaceutical Products and CMO Business (2015-2020))
  13.1.5 Catalent Recent Development
13.2 DPx
  13.2.1 DPx Company Details
  13.2.2 DPx Business Overview and Its Total Revenue
  13.2.3 DPx Pharmaceutical Products and CMO Introduction
  13.2.4 DPx Revenue in Pharmaceutical Products and CMO Business (2015-2020)
  13.2.5 DPx Recent Development
13.3 Lonza
  13.3.1 Lonza Company Details
  13.3.2 Lonza Business Overview and Its Total Revenue
  13.3.3 Lonza Pharmaceutical Products and CMO Introduction
  13.3.4 Lonza Revenue in Pharmaceutical Products and CMO Business (2015-2020)
  13.3.5 Lonza Recent Development
13.4 Piramal Healthcare
  13.4.1 Piramal Healthcare Company Details
  13.4.2 Piramal Healthcare Business Overview and Its Total Revenue
  13.4.3 Piramal Healthcare Pharmaceutical Products and CMO Introduction
  13.4.4 Piramal Healthcare Revenue in Pharmaceutical Products and CMO Business (2015-2020)
  13.4.5 Piramal Healthcare Recent Development
13.5 Aenova
  13.5.1 Aenova Company Details
  13.5.2 Aenova Business Overview and Its Total Revenue
  13.5.3 Aenova Pharmaceutical Products and CMO Introduction
  13.5.4 Aenova Revenue in Pharmaceutical Products and CMO Business (2015-2020)
  13.5.5 Aenova Recent Development
13.6 Jubilant
  13.6.1 Jubilant Company Details
  13.6.2 Jubilant Business Overview and Its Total Revenue
  13.6.3 Jubilant Pharmaceutical Products and CMO Introduction
  13.6.4 Jubilant Revenue in Pharmaceutical Products and CMO Business (2015-2020)
  13.6.5 Jubilant Recent Development
13.7 Famar
  13.7.1 Famar Company Details
  13.7.2 Famar Business Overview and Its Total Revenue
  13.7.3 Famar Pharmaceutical Products and CMO Introduction
  13.7.4 Famar Revenue in Pharmaceutical Products and CMO Business (2015-2020)
  13.7.5 Famar Recent Development
13.8 Boehringer Ingelheim
  13.8.1 Boehringer Ingelheim Company Details
  13.8.2 Boehringer Ingelheim Business Overview and Its Total Revenue
  13.8.3 Boehringer Ingelheim Pharmaceutical Products and CMO Introduction
  13.8.4 Boehringer Ingelheim Revenue in Pharmaceutical Products and CMO Business (2015-2020)
  13.8.5 Boehringer Ingelheim Recent Development
13.9 Fareva Holding
  13.9.1 Fareva Holding Company Details
  13.9.2 Fareva Holding Business Overview and Its Total Revenue
  13.9.3 Fareva Holding Pharmaceutical Products and CMO Introduction
  13.9.4 Fareva Holding Revenue in Pharmaceutical Products and CMO Business (2015-2020)
  13.9.5 Fareva Holding Recent Development
13.10 AbbVie
  13.10.1 AbbVie Company Details
  13.10.2 AbbVie Business Overview and Its Total Revenue
  13.10.3 AbbVie Pharmaceutical Products and CMO Introduction
  13.10.4 AbbVie Revenue in Pharmaceutical Products and CMO Business (2015-2020)
  13.10.5 AbbVie Recent Development
13.11 Nipro Corp
  10.11.1 Nipro Corp Company Details
  10.11.2 Nipro Corp Business Overview and Its Total Revenue
  10.11.3 Nipro Corp Pharmaceutical Products and CMO Introduction
  10.11.4 Nipro Corp Revenue in Pharmaceutical Products and CMO Business (2015-2020)
  10.11.5 Nipro Corp Recent Development
13.12 Vetter
  10.12.1 Vetter Company Details
  10.12.2 Vetter Business Overview and Its Total Revenue
  10.12.3 Vetter Pharmaceutical Products and CMO Introduction
  10.12.4 Vetter Revenue in Pharmaceutical Products and CMO Business (2015-2020)
  10.12.5 Vetter Recent Development
13.13 Sopharma
  10.13.1 Sopharma Company Details
  10.13.2 Sopharma Business Overview and Its Total Revenue
  10.13.3 Sopharma Pharmaceutical Products and CMO Introduction
  10.13.4 Sopharma Revenue in Pharmaceutical Products and CMO Business (2015-2020)
  10.13.5 Sopharma Recent Development
13.14 Mylan (DPT Laboratories)
  10.14.1 Mylan (DPT Laboratories) Company Details
  10.14.2 Mylan (DPT Laboratories) Business Overview and Its Total Revenue
  10.14.3 Mylan (DPT Laboratories) Pharmaceutical Products and CMO Introduction
  10.14.4 Mylan (DPT Laboratories) Revenue in Pharmaceutical Products and CMO Business (2015-2020)
  10.14.5 Mylan (DPT Laboratories) Recent Development
13.15 Recipharm
  10.15.1 Recipharm Company Details
  10.15.2 Recipharm Business Overview and Its Total Revenue
  10.15.3 Recipharm Pharmaceutical Products and CMO Introduction
  10.15.4 Recipharm Revenue in Pharmaceutical Products and CMO Business (2015-2020)
  10.15.5 Recipharm Recent Development
13.16 NextPharma Technologies
  10.16.1 NextPharma Technologies Company Details
  10.16.2 NextPharma Technologies Business Overview and Its Total Revenue
  10.16.3 NextPharma Technologies Pharmaceutical Products and CMO Introduction
  10.16.4 NextPharma Technologies Revenue in Pharmaceutical Products and CMO Business (2015-2020)
  10.16.5 NextPharma Technologies Recent Development
13.17 Dishman
  10.17.1 Dishman Company Details
  10.17.2 Dishman Business Overview and Its Total Revenue
  10.17.3 Dishman Pharmaceutical Products and CMO Introduction
  10.17.4 Dishman Revenue in Pharmaceutical Products and CMO Business (2015-2020)
  10.17.5 Dishman Recent Development
13.18 Aesica
  10.18.1 Aesica Company Details
  10.18.2 Aesica Business Overview and Its Total Revenue
  10.18.3 Aesica Pharmaceutical Products and CMO Introduction
  10.18.4 Aesica Revenue in Pharmaceutical Products and CMO Business (2015-2020)
  10.18.5 Aesica Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Pharmaceutical Products and CMO Key Market Segments
Table 2. Key Players Covered: Ranking by Pharmaceutical Products and CMO Revenue
Table 3. Ranking of Global Top Pharmaceutical Products and CMO Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Pharmaceutical Products and CMO Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Active Pharmaceutical Ingredient (API)
Table 6. Key Players of Finished Dosage Form (FDF)
Table 7. Key Players of Pharmaceutical Packaging
Table 8. COVID-19 Impact Global Market: (Four Pharmaceutical Products and CMO Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Pharmaceutical Products and CMO Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Pharmaceutical Products and CMO Players to Combat Covid-19 Impact
Table 13. Global Pharmaceutical Products and CMO Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Pharmaceutical Products and CMO Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Pharmaceutical Products and CMO Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Pharmaceutical Products and CMO Market Share by Regions (2015-2020)
Table 17. Global Pharmaceutical Products and CMO Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Pharmaceutical Products and CMO Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Pharmaceutical Products and CMO Market Growth Strategy
Table 23. Main Points Interviewed from Key Pharmaceutical Products and CMO Players
Table 24. Global Pharmaceutical Products and CMO Revenue by Players (2015-2020) (Million US$)
Table 25. Global Pharmaceutical Products and CMO Market Share by Players (2015-2020)
Table 26. Global Top Pharmaceutical Products and CMO Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceutical Products and CMO as of 2019)
Table 27. Global Pharmaceutical Products and CMO by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Pharmaceutical Products and CMO Product Solution and Service
Table 30. Date of Enter into Pharmaceutical Products and CMO Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Pharmaceutical Products and CMO Market Size by Type (2015-2020) (Million US$)
Table 33. Global Pharmaceutical Products and CMO Market Size Share by Type (2015-2020)
Table 34. Global Pharmaceutical Products and CMO Revenue Market Share by Type (2021-2026)
Table 35. Global Pharmaceutical Products and CMO Market Size Share by Application (2015-2020)
Table 36. Global Pharmaceutical Products and CMO Market Size by Application (2015-2020) (Million US$)
Table 37. Global Pharmaceutical Products and CMO Market Size Share by Application (2021-2026)
Table 38. North America Key Players Pharmaceutical Products and CMO Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Pharmaceutical Products and CMO Market Share (2019-2020)
Table 40. North America Pharmaceutical Products and CMO Market Size by Type (2015-2020) (Million US$)
Table 41. North America Pharmaceutical Products and CMO Market Share by Type (2015-2020)
Table 42. North America Pharmaceutical Products and CMO Market Size by Application (2015-2020) (Million US$)
Table 43. North America Pharmaceutical Products and CMO Market Share by Application (2015-2020)
Table 44. Europe Key Players Pharmaceutical Products and CMO Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Pharmaceutical Products and CMO Market Share (2019-2020)
Table 46. Europe Pharmaceutical Products and CMO Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Pharmaceutical Products and CMO Market Share by Type (2015-2020)
Table 48. Europe Pharmaceutical Products and CMO Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Pharmaceutical Products and CMO Market Share by Application (2015-2020)
Table 50. China Key Players Pharmaceutical Products and CMO Revenue (2019-2020) (Million US$)
Table 51. China Key Players Pharmaceutical Products and CMO Market Share (2019-2020)
Table 52. China Pharmaceutical Products and CMO Market Size by Type (2015-2020) (Million US$)
Table 53. China Pharmaceutical Products and CMO Market Share by Type (2015-2020)
Table 54. China Pharmaceutical Products and CMO Market Size by Application (2015-2020) (Million US$)
Table 55. China Pharmaceutical Products and CMO Market Share by Application (2015-2020)
Table 56. Japan Key Players Pharmaceutical Products and CMO Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Pharmaceutical Products and CMO Market Share (2019-2020)
Table 58. Japan Pharmaceutical Products and CMO Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Pharmaceutical Products and CMO Market Share by Type (2015-2020)
Table 60. Japan Pharmaceutical Products and CMO Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Pharmaceutical Products and CMO Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Pharmaceutical Products and CMO Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Pharmaceutical Products and CMO Market Share (2019-2020)
Table 64. Southeast Asia Pharmaceutical Products and CMO Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Pharmaceutical Products and CMO Market Share by Type (2015-2020)
Table 66. Southeast Asia Pharmaceutical Products and CMO Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Pharmaceutical Products and CMO Market Share by Application (2015-2020)
Table 68. India Key Players Pharmaceutical Products and CMO Revenue (2019-2020) (Million US$)
Table 69. India Key Players Pharmaceutical Products and CMO Market Share (2019-2020)
Table 70. India Pharmaceutical Products and CMO Market Size by Type (2015-2020) (Million US$)
Table 71. India Pharmaceutical Products and CMO Market Share by Type (2015-2020)
Table 72. India Pharmaceutical Products and CMO Market Size by Application (2015-2020) (Million US$)
Table 73. India Pharmaceutical Products and CMO Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Pharmaceutical Products and CMO Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Pharmaceutical Products and CMO Market Share (2019-2020)
Table 76. Central & South America Pharmaceutical Products and CMO Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Pharmaceutical Products and CMO Market Share by Type (2015-2020)
Table 78. Central & South America Pharmaceutical Products and CMO Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Pharmaceutical Products and CMO Market Share by Application (2015-2020)
Table 80. Catalent Company Details
Table 81. Catalent Business Overview
Table 82. Catalent Product
Table 83. Catalent Revenue in Pharmaceutical Products and CMO Business (2015-2020) (Million US$)
Table 84. Catalent Recent Development
Table 85. DPx Company Details
Table 86. DPx Business Overview
Table 87. DPx Product
Table 88. DPx Revenue in Pharmaceutical Products and CMO Business (2015-2020) (Million US$)
Table 89. DPx Recent Development
Table 90. Lonza Company Details
Table 91. Lonza Business Overview
Table 92. Lonza Product
Table 93. Lonza Revenue in Pharmaceutical Products and CMO Business (2015-2020) (Million US$)
Table 94. Lonza Recent Development
Table 95. Piramal Healthcare Company Details
Table 96. Piramal Healthcare Business Overview
Table 97. Piramal Healthcare Product
Table 98. Piramal Healthcare Revenue in Pharmaceutical Products and CMO Business (2015-2020) (Million US$)
Table 99. Piramal Healthcare Recent Development
Table 100. Aenova Company Details
Table 101. Aenova Business Overview
Table 102. Aenova Product
Table 103. Aenova Revenue in Pharmaceutical Products and CMO Business (2015-2020) (Million US$)
Table 104. Aenova Recent Development
Table 105. Jubilant Company Details
Table 106. Jubilant Business Overview
Table 107. Jubilant Product
Table 108. Jubilant Revenue in Pharmaceutical Products and CMO Business (2015-2020) (Million US$)
Table 109. Jubilant Recent Development
Table 110. Famar Company Details
Table 111. Famar Business Overview
Table 112. Famar Product
Table 113. Famar Revenue in Pharmaceutical Products and CMO Business (2015-2020) (Million US$)
Table 114. Famar Recent Development
Table 115. Boehringer Ingelheim Business Overview
Table 116. Boehringer Ingelheim Product
Table 117. Boehringer Ingelheim Company Details
Table 118. Boehringer Ingelheim Revenue in Pharmaceutical Products and CMO Business (2015-2020) (Million US$)
Table 119. Boehringer Ingelheim Recent Development
Table 120. Fareva Holding Company Details
Table 121. Fareva Holding Business Overview
Table 122. Fareva Holding Product
Table 123. Fareva Holding Revenue in Pharmaceutical Products and CMO Business (2015-2020) (Million US$)
Table 124. Fareva Holding Recent Development
Table 125. AbbVie Company Details
Table 126. AbbVie Business Overview
Table 127. AbbVie Product
Table 128. AbbVie Revenue in Pharmaceutical Products and CMO Business (2015-2020) (Million US$)
Table 129. AbbVie Recent Development
Table 130. Nipro Corp Company Details
Table 131. Nipro Corp Business Overview
Table 132. Nipro Corp Product
Table 133. Nipro Corp Revenue in Pharmaceutical Products and CMO Business (2015-2020) (Million US$)
Table 134. Nipro Corp Recent Development
Table 135. Vetter Company Details
Table 136. Vetter Business Overview
Table 137. Vetter Product
Table 138. Vetter Revenue in Pharmaceutical Products and CMO Business (2015-2020) (Million US$)
Table 139. Vetter Recent Development
Table 140. Sopharma Company Details
Table 141. Sopharma Business Overview
Table 142. Sopharma Product
Table 143. Sopharma Revenue in Pharmaceutical Products and CMO Business (2015-2020) (Million US$)
Table 144. Sopharma Recent Development
Table 145. Mylan (DPT Laboratories) Company Details
Table 146. Mylan (DPT Laboratories) Business Overview
Table 147. Mylan (DPT Laboratories) Product
Table 148. Mylan (DPT Laboratories) Revenue in Pharmaceutical Products and CMO Business (2015-2020) (Million US$)
Table 149. Mylan (DPT Laboratories) Recent Development
Table 150. Recipharm Company Details
Table 151. Recipharm Business Overview
Table 152. Recipharm Product
Table 153. Recipharm Revenue in Pharmaceutical Products and CMO Business (2015-2020) (Million US$)
Table 154. Recipharm Recent Development
Table 155. NextPharma Technologies Company Details
Table 156. NextPharma Technologies Business Overview
Table 157. NextPharma Technologies Product
Table 158. NextPharma Technologies Revenue in Pharmaceutical Products and CMO Business (2015-2020) (Million US$)
Table 159. NextPharma Technologies Recent Development
Table 160. Dishman Company Details
Table 161. Dishman Business Overview
Table 162. Dishman Product
Table 163. Dishman Revenue in Pharmaceutical Products and CMO Business (2015-2020) (Million US$)
Table 164. Dishman Recent Development
Table 165. Aesica Company Details
Table 166. Aesica Business Overview
Table 167. Aesica Product
Table 168. Aesica Revenue in Pharmaceutical Products and CMO Business (2015-2020) (Million US$)
Table 169. Aesica Recent Development
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Pharmaceutical Products and CMO Market Share by Type: 2020 VS 2026
Figure 2. Active Pharmaceutical Ingredient (API) Features
Figure 3. Finished Dosage Form (FDF) Features
Figure 4. Pharmaceutical Packaging Features
Figure 5. Global Pharmaceutical Products and CMO Market Share by Application: 2020 VS 2026
Figure 6. Specialty/Midsize Case Studies
Figure 7. Generics Case Studies
Figure 8. Big Pharma Case Studies
Figure 9. Others Case Studies
Figure 10. Pharmaceutical Products and CMO Report Years Considered
Figure 11. Global Pharmaceutical Products and CMO Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Pharmaceutical Products and CMO Market Share by Regions: 2020 VS 2026
Figure 13. Global Pharmaceutical Products and CMO Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Pharmaceutical Products and CMO Market Share by Players in 2019
Figure 16. Global Top Pharmaceutical Products and CMO Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceutical Products and CMO as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Pharmaceutical Products and CMO Revenue in 2019
Figure 18. North America Pharmaceutical Products and CMO Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Pharmaceutical Products and CMO Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Pharmaceutical Products and CMO Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Pharmaceutical Products and CMO Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Pharmaceutical Products and CMO Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Pharmaceutical Products and CMO Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Pharmaceutical Products and CMO Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Catalent Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Catalent Revenue Growth Rate in Pharmaceutical Products and CMO Business (2015-2020)
Figure 27. DPx Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. DPx Revenue Growth Rate in Pharmaceutical Products and CMO Business (2015-2020)
Figure 29. Lonza Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Lonza Revenue Growth Rate in Pharmaceutical Products and CMO Business (2015-2020)
Figure 31. Piramal Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Piramal Healthcare Revenue Growth Rate in Pharmaceutical Products and CMO Business (2015-2020)
Figure 33. Aenova Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Aenova Revenue Growth Rate in Pharmaceutical Products and CMO Business (2015-2020)
Figure 35. Jubilant Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Jubilant Revenue Growth Rate in Pharmaceutical Products and CMO Business (2015-2020)
Figure 37. Famar Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Famar Revenue Growth Rate in Pharmaceutical Products and CMO Business (2015-2020)
Figure 39. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Boehringer Ingelheim Revenue Growth Rate in Pharmaceutical Products and CMO Business (2015-2020)
Figure 41. Fareva Holding Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Fareva Holding Revenue Growth Rate in Pharmaceutical Products and CMO Business (2015-2020)
Figure 43. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. AbbVie Revenue Growth Rate in Pharmaceutical Products and CMO Business (2015-2020)
Figure 45. Nipro Corp Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Nipro Corp Revenue Growth Rate in Pharmaceutical Products and CMO Business (2015-2020)
Figure 47. Vetter Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Vetter Revenue Growth Rate in Pharmaceutical Products and CMO Business (2015-2020)
Figure 49. Sopharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Sopharma Revenue Growth Rate in Pharmaceutical Products and CMO Business (2015-2020)
Figure 51. Mylan (DPT Laboratories) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Mylan (DPT Laboratories) Revenue Growth Rate in Pharmaceutical Products and CMO Business (2015-2020)
Figure 53. Recipharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Recipharm Revenue Growth Rate in Pharmaceutical Products and CMO Business (2015-2020)
Figure 55. NextPharma Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. NextPharma Technologies Revenue Growth Rate in Pharmaceutical Products and CMO Business (2015-2020)
Figure 57. Dishman Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Dishman Revenue Growth Rate in Pharmaceutical Products and CMO Business (2015-2020)
Figure 59. Aesica Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Aesica Revenue Growth Rate in Pharmaceutical Products and CMO Business (2015-2020)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed